Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Benitec Biopharma Inc have a median target of 16.50, with a high estimate of 30.00 and a low estimate of 13.00. The median estimate represents a 91.30% increase from the last price of 8.63.
High | 247.8% | 30.00 |
Med | 91.3% | 16.50 |
Low | 50.7% | 13.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | +10.16% |
Average growth rate | -9.47% |
More ▼
Revenue history & estimates in USD
Average growth rate | -46.76% |
Average growth rate | -5.23% |
More ▼